GOSS earnings: a negative outcome, -6.4%

On May 7, 2024, Gossamer Bio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.4% in the window around the event. It had already run -28.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.